Osteoarthritis
By D. Hunter, David T Felson. The Lancet, 2006
4,735 citations recorded by the source corpus.
Osteoarthritis is a leading cause of disability and source of societal cost in older adults. With an ageing and increasingly obese population, this syndrome is becoming even more prevalent than in previous decades. In recent years, we have gained important insights into the cause and pathogenesis of pain in osteoarthritis. The diagnosis of osteoarthritis is clinically based despite the widespread overuse of imaging methods. Management should be tailored to the presenting individual and focus on core treatments, including self-management and education, exercise, and weight loss as relevant. Surgery should be reserved for those that have not responded appropriately to less invasive methods. Prevention and disease modification are areas being targeted by various research endeavours, which have indicated great potential thus far. This narrative Seminar provides an update on the pathogenesis, diagnosis, management, and future research on osteoarthritis for a clinical audience.
Subfields: Pharmacology, Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/8e20e80f422b0879059caabb356e6e380740e048
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Mingxi Lin
- Yizi Jin
- Xin Shen
- Xuran Li
- Jialin C. Zheng
- Jiaojiao Li
- C. Zeng
- Qing Guo
Citations in the corpus
- NF-κB in biology and targeted therapy: new insights and translational implications (2024, background): “322 The NF-κ B pathway actively participates in and regulates various aspects of chondrocyte function, including proliferation, differentiation, apoptosis, and bone matrix metabolism.”
- Clinical applications of stem cell-derived exosomes (2024, background): “78 Clinical trials have successfully revealed systemic compounds that arrest structural progression (e.g., cathepsin K and Wnt inhibitors) or reduce OA pain (e.g., nerve growth factor inhibitors).”
- Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies (2020, neutral): “1 (cid:1) 56, p 0 (cid:1) 00) times as much as males, respectively, which was corresponded to established consensus [1,29].”